Leukemia Research
Volume 29, Issue 2 , Pages 235-236, February 2005

Thalidomide therapy for low-risk Myelodysplasia

  • David Bowen

      Affiliations

    • Department of Haematology, Ninewells Hospital, Dundee, Scotland, UK
    • Corresponding Author InformationCorresponding author. Present address: Division of Pathology and Neurosciences, Ninewells Hospital, Dundee DD21HY, Scotland, UK. Tel.: +44 1382 660111; fax: +44 1382 645731.
  • ,
  • Louisa MacIlwaine

      Affiliations

    • Department of Haematology, Ninewells Hospital, Dundee, Scotland, UK
  • ,
  • Jamie Cavanagh

      Affiliations

    • Department of Haematology, St. Bartholomew’s and Royal London Medical School, London, England, UK
  • ,
  • Sally Killick

      Affiliations

    • Department of Haematology, Royal Bournemouth Hospital, Bournemouth, England, UK
  • ,
  • Dominic Culligan

      Affiliations

    • Department of Haematology, Aberdeen Royal Hospitals, Aberdeen, Scotland, UK
  • ,
  • Ewan Thomson

      Affiliations

    • DDS Medicines Research, Ninewells Hospital, Dundee, Scotland, UK
  • ,
  • Ghulam Mufti

      Affiliations

    • Department of Haematological Medicine, Kings College Hospital, London, England, UK

Received 29 April 2004; accepted 6 May 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 On behalf of the UK MDS Forum.

PII: S0145-2126(04)00231-0

doi:10.1016/j.leukres.2004.05.017

Leukemia Research
Volume 29, Issue 2 , Pages 235-236, February 2005